Hurthle cell thyroid cancer (also called Hurtle cell carcinoma) is a rare sub-type of follicular thyroid cancer. Approximately 3% of thyroid cancer cases are Hurthle cell. Hurthle thyroid cells can be ...

Papillary and follicular thyroid cancers are considered well-differentiated cancers. Papillary thyroid cancer is the most prevalent type of thyroid cancer--with over 50,000 new cases per year in the ...

Papillary, follicular, and medullary thyroid cancers all have a 99.5% five-year relative survival rate for localized cancers ...

One of the most difficult issues to deal with as a cancer survivor is the positivity trap. Four and a half years ago, I was diagnosed with follicular lymphoma, a form of blood cancer that is ...

There are several types of thyroid cancer, including: papillary thyroid cancer follicular thyroid cancer oncocytic cell (hurthle cell) thyroid cancer medullary thyroid cancer anaplastic thyroid ...

Thyroid cancers are tumours of the thyroid gland, and originate from follicular or parafollicular ... The treatment of poorly differentiated thyroid cancer and anaplastic thyroid cancer remains ...

PAX8-PPAR γ and RAS mutations tend to correlate with specific phenotypical features of follicular carcinomas. Targeted therapy for thyroid cancer with BRAF and RET inhibitors has progressed to ...

predominantly follicular lesion in 50 cases, and suspicious or malignant lesion in 16 cases. The final pathology revealed a benign nodule in 98 cases (82.4%) and a carcinoma in 21 (17.6%).

Despite being declared cancer-free after initial treatment, I grapple with survivor's guilt, questioning why my lymphoma responded to therapy while others did not. When I started receiving treatment ...